Search Results
The long-term efficacy of acalabrutinib-based regimens in patients with CLL
Efficacy of zanubrutinib in acalabrutinib-intolerant patients with B-cell malignancies
Investigating the safety and efficacy of re-treating CLL patients with venetoclax-based regimens
MAJIC: Venetoclax with acalabrutinib or obinutuzumab in CLL
The current role of acalabrutinib in the treatment of CLL
Acalabrutinib in patients with CLL and MCL undergoing alloSCT
Evaluating acalabrutinib in CLL treatment
EPIC update: observational study of first-line acalabrutinib treatment for CLL
Data + Perspectives: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (4 of 5)
The safety and efficacy of tirabrutinib and entospletinib with or without obinutuzumab in R/R CLL
Acalabrutinib Shows Promising Results for the Treatment of CLL
Selecting the best treatment option in CLL
